From January 1, 2024, guaranteed purchase contracts for pharmaceutical products in Uzbekistan will be concluded for up to 10 years
Uzbekistan extends the period of guaranteed purchase of localized pharmaceutical products
Pharmaceutical business in Uzbekistan
The pharmaceutical business in Uzbekistan is an important sector of the economy, which is in the stage of active development and modernization. Our site offers articles on the main aspects of the pharmaceutical industry in the country, its contribution to healthcare and economic development.
Explore the current state of the pharmaceutical business in Uzbekistan, including the production, import and export of medical and pharmaceutical products. Find out about government initiatives to stimulate domestic production of medicines and improve product quality. Gain insight into key challenges such as the need to improve production capacity, attract investment and update pharmaceutical legislation. Discuss the prospects for the development of pharmaceutical business in Uzbekistan, including opportunities for deepening the localization of production and expanding into international markets. Get advice for entrepreneurs and investors interested in entering the Uzbekistan pharmaceutical market, including analyzing market trends and assessing investment potential.
Distributor of a drug that killed more than 65 children in Uzbekistan asks for permission to sell other drugs
The Uzbek Pharmaceutical Agency, in turn, is seeking the destruction of all drugs from India’s Marion Biotech
The Agency for the Development of the Pharmaceutical Industry of Uzbekistan, together with USAID, is implementing a project to diversify the Asian pharmaceutical supply chain
The DAPSC will be implemented with technical assistance from the USAID Program for the Advancement of Quality Medicines Plus (PQM+).
Starting from September 2023, pharmacists and doctors of Uzbekistan will be required to undergo an online procedure for obtaining a qualification category
Attestations for the qualification category will begin on September 16 this year. The rest of the medical staff will be subject to this innovation on January 1, 2024.